MEDI&GENE, a biopharmaceutical company developing therapeutics for metabolic diseases, announced today that it has entered into a Catalyze agreement with Eli Lilly and Company (Lilly) to advance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results